← Back to Search

Drug-specific alert for Acute Kidney Injury

N/A

Waitlist Available

Research Sponsored by Yale University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up assessed at the point of discharge from index hospitalization, up to 365 days post randomization

Awards & highlights

Study Summary

This trial is testing whether placing an alert in the electronic health record for patients with acute kidney injury who have recently received a drug that may affect kidney function will improve patient outcomes.

Eligible Conditions

Acute Kidney Injury

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ assessed at the point of discharge from index hospitalization, up to 365 days post randomization

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~assessed at the point of discharge from index hospitalization, up to 365 days post randomization

This trial's timeline: 3 weeks for screening, Varies for treatment, and assessed at the point of discharge from index hospitalization, up to 365 days post randomization for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Percentage of Patients With Progression of AKI OR Dialysis OR Death

Secondary outcome measures

14- Day Mortality Rate

AKI Duration

Index Hospitalization Cost

+10 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Drug-specific alertExperimental Treatment1 Intervention

A drug-specific AKI alert, including information about the drug of interest as well as the presence of AKI will be fired.

Group II: Usual CareActive Control1 Intervention

No alert will be fired.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Yale UniversityLead Sponsor

1,847 Previous Clinical Trials

2,732,608 Total Patients Enrolled

9 Trials studying Acute Kidney Injury

19,790 Patients Enrolled for Acute Kidney Injury

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH

2,357 Previous Clinical Trials

4,310,126 Total Patients Enrolled

24 Trials studying Acute Kidney Injury

21,740 Patients Enrolled for Acute Kidney Injury

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants have thus far been enrolled in this clinical research?

"Affirmative. According to records on clinicaltrials.gov, this trial has been actively searching for participants since August 24th 2020 and is presently recruiting 5000 patients from a single location."

Answered by AI

Are individuals being recruited for this scientific trial currently?

"Clinicaltrials.gov advertises that this experiment is presently in need of participants, having started on August 24th 2020 and been updated most recently on October 18th 2022."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Drug-Targeted Alerts for Acute Kidney Injury

2020. "Drug-Targeted Alerts for Acute Kidney Injury". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02771977.